Patents by Inventor Engler Heidrun

Engler Heidrun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070009485
    Abstract: The present invention provides formulations and methods to enhance the delivery of nucleic acids to cells. Formulations comprising dextrin polymers in combination with sugars provide enhanced delivery of nucleic acids, particularly eucaryotic expression vectors, demonstrate enhanced delivery of nucleic acids to cells in vivo. The present invention also provides methods of treatment in combination with such formulations.
    Type: Application
    Filed: May 25, 2006
    Publication date: January 11, 2007
    Inventors: Susan Conroy, Engler Heidrun, Daniel Maneval
  • Patent number: 7094583
    Abstract: The present invention provides formulations and methods to enhance the delivery of nucleic acids to cells. Formulations comprising dextrin polymers in combination with sugars provide enhanced delivery of nucleic acids, particularly eucaryotic expression vectors, demonstrate enhanced delivery of nucleic acids to cells in vivo. The present invention also provides methods of treatment in combination with such formulations.
    Type: Grant
    Filed: August 6, 2004
    Date of Patent: August 22, 2006
    Assignees: Canji, Inc., Innovata PLC
    Inventors: Susan E. Conroy, Engler Heidrun, Daniel C. Maneval
  • Patent number: 5789244
    Abstract: A method and pharmaceutical composition for the treatment of cancer using a gene delivery system, such as a viral vector delivery system, comprising a therapeutic gene wherein the gene delivery system is formulated in a buffer comprising a delivery-enhancing agent such as ethanol.
    Type: Grant
    Filed: January 8, 1996
    Date of Patent: August 4, 1998
    Assignee: Canji, Inc.
    Inventors: Engler Heidrun, Dan Maneval